CD8A and COVID-19: In addition, patients with severe/critical COVID-19 exhibited increased pro-inflammatory immune cell markers and lower number of CD8+ T cells and their gut microbiome was characterized by decreased anti-inflammatory butyrate-producing bacterial genera Faecalibacterium and Roseburia, and alterations of bacterial networks of bacteria with anti-inflammatory properties compared to patients with mild COVID-19 illness.